Cargando…
Clinical trial perspective for adult and juvenile Huntington's disease using genetically-engineered mesenchymal stem cells
Progress to date from our group and others indicate that using genetically-engineered mesenchymal stem cells (MSC) to secrete brain-derived neurotrophic factor (BDNF) supports our plan to submit an Investigational New Drug application to the Food and Drug Administration for the future planned Phase...
Autores principales: | Deng, Peter, Torrest, Audrey, Pollock, Kari, Dahlenburg, Heather, Annett, Geralyn, Nolta, Jan A., Fink, Kyle D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904446/ https://www.ncbi.nlm.nih.gov/pubmed/27335539 http://dx.doi.org/10.4103/1673-5374.182682 |
Ejemplares similares
-
Developing stem cell therapies for juvenile and adult-onset Huntington’s disease
por: Fink, Kyle D, et al.
Publicado: (2015) -
Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models
por: Pollock, Kari, et al.
Publicado: (2016) -
Genetically Engineered Mesenchymal Stem Cells as a Proposed Therapeutic for Huntington’s Disease
por: Olson, Scott D., et al.
Publicado: (2011) -
A novel Huntington's disease mouse model to assess the role of neuroinflammation on disease progression and to develop human cell therapies
por: Dahlenburg, Heather, et al.
Publicado: (2021) -
Human Myoblast and Mesenchymal Stem Cell Interactions Visualized by Videomicroscopy
por: Black, Amanda B., et al.
Publicado: (2015)